(PubMed) Sethumadhavan S, Chinnakannu P
JohnsonSCYanosMEKayserEBQuintanaASangeslandMCastanzaAet al
Study design and study population We identified three study cohorts of patients who started SGLT-2 inhibitors versus DPP-4 inhibitors (cohort 1), GLP-1 receptor agonists versus DPP-4 inhibitors (cohort 2), and SGLT-2 inhibitors versus GLP-1 receptor agonists (cohort 3) from April 2013 to the end of available data (December 2019 in Medicare, December 2020 in MarketScan, and April 2022 in CDM)
Diabetes 49 , 677683 (2000)
Unser Krper stellt eine Reihe von Antioxidantien her, und wir produzieren vor allem ein kleines Molekl, das Glutathion, das aus drei Aminosuren (Glycin, Cystein und Glutaminsure) besteht
mTOR signals are a kind of master control switch, directing cells to grow and multiply